
European Economic AreaBiocidal Products Regulation (BPR)
BPC-55 Adopts Opinions Supporting Biocide Approvals, Renewals And Union Authorisations
At BPC-55 in May 2025, ECHA’s committee adopted scientific opinions supporting biocide approvals, renewals and authorisations. The opinions did not themselves grant those legal decisions.
Published in June 2025. Dates, deadlines and stages may have changed since.
2 min readAI-drafted, expert reviewed

ECHA's Biocidal Products Committee adopted opinions supporting active-substance approvals, renewals and Union-authorisation applications at its May 2025 meeting. ECHA’s announcement distinguishes those opinions from the final decisions taken by the Commission and Member States.
Active-Substance Opinions
The committee supported approval of IPBC for product-type 10, building-material preservatives, and alpha-bromadiolone for product-type 14, rodenticides.
It also supported renewal of seven existing anticoagulant rodenticides: brodifacoum, flocoumafen, coumatetralyl, chlorophacinone, difethialone, difenacoum and bromadiolone. These substances act as vitamin K antagonists.
BPC did not support use against mice by non-professionals or permanent baiting by professional pest controllers where safer alternatives were available. These were opinion conclusions, not bans enacted at the meeting.
Union-Authorisation Dossiers
Five opinions concerned four new Union authorisations and one major change to an existing authorisation:
- Active chlorine from hypochlorous acid for product-types 1 and 3.
- Potassium sorbate for product-type 6.
- One hydrogen peroxide family for product-types 2, 3 and 4.
- Another hydrogen peroxide family for product-types 3 and 4.
- A major change to a product-type 18 product combining pyriproxyfen and clothianidin.
All five opinions were adopted by consensus.
Technical And Mutual-Recognition Work
The committee updated environmental endpoints for pyrethroid metabolites, focusing on degradation half-lives. It also adopted an Article 75(1)(g) opinion on a hydrogen peroxide product family's fungal uses.
Three Article 38 opinions provided input to Commission consideration of unresolved mutual-recognition objections concerning product-types 2, 3 and 19. The meeting report is not a register of subsequent legal authorisations or current product conditions.
Official source
echa.europa.euQuestions about this change
Which substances were discussed at ECHA's BPC-55 meeting in May 2025?
ECHA's BPC-55 meeting discussed IPBC, alpha-bromadiolone and seven existing rodenticides. Union authorisation dossiers also concerned hydrogen peroxide, potassium sorbate and hypochlorous acid.
Did ECHA's BPC-55 opinions themselves grant biocidal product authorisations?
No. ECHA's BPC-55 opinions are part of the biocides decision process. The committee's adoption of an opinion does not itself grant a product authorisation.

Dr Steven Brennan
CEO and co-founder of Foresight, and a co-opted member of ECHA's Committee for Socio-economic Analysis. He holds a PhD in chemical engineering.
More from Dr Steven BrennanFind out what this means for your products
Foresight follows changes like this one and shows where they reach your substances, products and markets.
Join 3,500+ professionals staying ahead
Foresight Weekly brings the week's regulatory changes across chemicals, product safety, sustainability, ESG and EHS into one email.
Read by professionals at

